Skip to main content

Table 1 Characteristics of included studies

From: The effect of rigorous study design in the research of autologous bone marrow-derived mononuclear cell transfer in patients with acute myocardial infarction

Study BMSC (n) Control (n) Cell dose Injection time Baseline LVEF (%) Follow-up
Cao et al.[19] 41 45 5 × 108 7 days 38.8 6 mo
Chang et al. [20] 20 20 1.5 × 109 3 days 52.9 6 mo
Grajeck et al.[21] 31 14 0.41 × 109 4–5 days 55.5 6 mo
Herbots et al.[2] 33 34 3.04 × 108 4–7 days 55.5 4 mo
Huikuri et al.[3] 36 36 4.02 × 108 2.5 days 56.5 6 mo
Meluzin et al.[22] 20 20 1 × 108 5–9 days 40.5 6 mo
Penicka et al.[23] 17 10 26.4 × 108 4–11 days 39 4 mo
Piepoli et al.[24] 19 19 2.48 × 108 4 days 38.7 6 mo
Plewka et al.[25]) 40 20 1.44 × 108 7 days 34 6 mo
Schachinger et al.[4] 101 103 2.36 × 108 3–6 days 47.1 4 mo
Suarez de Lezo et al. [26] 10 10 9 × 108 7 days 38 3 mo
Tendera et al.[27] 80 40 1.78 × 108 7 days 37 6 mo
Traverse et al.[5] 30 10 1.5 × 108 4.5 days 38 6 mo
Traverse et al.[6] 58 29 1.5 × 108 14–21 days 47 6 mo
Wohrle et al.[7] 29 13 3.81 × 108 5–7 days 59.6 6 mo
Wollert et al.[28] 30 30 24.6 × 108 4.8 days 50.7 6 mo
Yao et al.[29] 12 12 2.0 × 108 3–7 days 32.4 6 mo
  1. BMSC bone marrow stem cell, LVEF left ventricular ejection fraction.